UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An analysis of clinical outcomes of 91 pregnancies in 83 women treated with danaparoid (Orgaran® )

Thrombosis research, 2010-04, Vol.125 (4), p.297-302

Magnani, H.N

2010

Volltextzugriff (PDF)

A review of 122 published outcomes of danaparoid anticoagulation for intermittent haemodialysis

Thrombosis research, 2010-04, Vol.125 (4), p.e171-e176

Magnani, H.N

2010

Volltextzugriff (PDF)

Characterization of the Collimation of an Atomic Beam with a Monochromatic Quasi-resonant Laser

Brazilian journal of physics, 2021-06, Vol.51 (3), p.329-338

2021

Volltextzugriff (PDF)

Mirror-assisted backscattering interferometry to measure the first-order correlation function of the light emitted by quantum scatterers

Physical review. A, 2021-11, Vol.104 (5), Article 053716

2021

Volltextzugriff (PDF)

Compassionate-use of the heparinoid orgaran (ORG 10172) particularly in patients with hit

Thrombosis research, 1992, Vol.65, p.S116-S116

1992

Volltextzugriff (PDF)

Orgaran in Heparin-lnduced Thrombocytopenia

Pathophysiology of haemostasis and thrombosis, 1992-02, Vol.22 (2), p.85-91

1992

Volltextzugriff (PDF)

Pharmacokinetic considerations on Orgaran (Org 10172) therapy

Haemostasis, 1992, Vol.22 (2), p.73-84

1992

Volltextzugriff (PDF)

Results of compassionate (named patient) use of the low molecular weight anticoagulant Org 10172 (Lomoparan)

Fibrinolysis, 1990, Vol.4, p.51-51

Magnani, H.N.

1990

Volltextzugriff (PDF)

Studies on the clinical use and physico-chemical characteristics of Lp-X, an abnormal cholestasis lipoprotein

Magnani, H.N

1975

Volltextzugriff (PDF)

Interactions study of the low molecular weight heparinoid Org 10172 (lomoparan ®) and acetylsalicylic acid in healthy male volunteers

European journal of pharmacology, 1990, Vol.183 (2), p.641-641

1990

Volltextzugriff (PDF)

PARTIAL ILEAL BYPASS IN FAMILIAL HYPERCHOLESTEROLAEMIA

The Lancet (British edition), 1981-11, Vol.318 (8256), p.1179-1179

Magnani, H.N.

1981

Volltextzugriff (PDF)

Early clinical experience of a new heparinoid, ORG 10172, in prevention of deep venous thrombosis

Thrombosis research, 1987-03, Vol.45 (5), p.497-503

1987

Volltextzugriff (PDF)

A study of methods of identification and estimation of LP(a) lipoprotein and of its significance in health, hyperlipidaemia and atherosclerosis

Atherosclerosis, 1974-09, Vol.20 (2), p.323-346

1974

Volltextzugriff (PDF)

A method for the quantitative determination of the abnormal lipoprotein (LP-X) of obstructive jaundice

Clinica chimica acta, 1972-05, Vol.38 (2), p.405-411

1972

Volltextzugriff (PDF)

The influence of LP-X and other lipoproteins associated with hepatic dysfunction on the activity of lecithin :Cholesterol acyltransferase

Biochimica et biophysica acta, 1976-12, Vol.450 (3), p.390-401

Magnani, H.N.

1976

Volltextzugriff (PDF)

Serum lipoprotein-X (LP-X) and biliary atresia (BA). Does an accurate diagnosis obtain?

Gastroenterology (New York, N.Y. 1943), 1978-11, Vol.75 (5), p.981-981

1978

Volltextzugriff (PDF)

DIURETIC-INDUCED HYPERTEIGLYCERIDÆMIA

The Lancet (British edition), 1976-05, Vol.307 (7967), p.1019-1019

1976

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(16)
Dissertationen
(1)

Sprache

Englisch
(17)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

An analysis of clinical outcomes of 91 pregnancies in 83 women treated with danaparoid (Orgaran® )

A review of 122 published outcomes of danaparoid anticoagulation for intermittent haemodialysis

Characterization of the Collimation of an Atomic Beam with a Monochromatic Quasi-resonant Laser

Mirror-assisted backscattering interferometry to measure the first-order correlation function of the light emitted by quantum scatterers

Compassionate-use of the heparinoid orgaran (ORG 10172) particularly in patients with hit

Orgaran in Heparin-lnduced Thrombocytopenia

Pharmacokinetic considerations on Orgaran (Org 10172) therapy

Results of compassionate (named patient) use of the low molecular weight anticoagulant Org 10172 (Lomoparan)

Studies on the clinical use and physico-chemical characteristics of Lp-X, an abnormal cholestasis lipoprotein

Interactions study of the low molecular weight heparinoid Org 10172 (lomoparan ®) and acetylsalicylic acid in healthy male volunteers

PARTIAL ILEAL BYPASS IN FAMILIAL HYPERCHOLESTEROLAEMIA

Early clinical experience of a new heparinoid, ORG 10172, in prevention of deep venous thrombosis

A study of methods of identification and estimation of LP(a) lipoprotein and of its significance in health, hyperlipidaemia and atherosclerosis

A method for the quantitative determination of the abnormal lipoprotein (LP-X) of obstructive jaundice

The influence of LP-X and other lipoproteins associated with hepatic dysfunction on the activity of lecithin :Cholesterol acyltransferase

Serum lipoprotein-X (LP-X) and biliary atresia (BA). Does an accurate diagnosis obtain?

DIURETIC-INDUCED HYPERTEIGLYCERIDÆMIA

Suchergebnisse filtern